buserelin has been researched along with Gestational Luteoma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Catalano, PN; Chamson-Reig, A; Fernández, MO; Libertun, C; Lux-Lantos, VA; Pignataro, OP; Sorianello, EM | 1 |
Chamson-Reig, A; Libertun, C; Lux-Lantos, V; Tesone, M | 1 |
Chamson-Reig, A; Libertun, C; Lux-Lantos, VA; Pignataro, OP | 1 |
3 other study(ies) available for buserelin and Gestational Luteoma
Article | Year |
---|---|
Gonadotropin-releasing hormone signaling pathways in an experimental ovarian tumor.
Topics: Adenylyl Cyclases; Animals; Antineoplastic Agents, Hormonal; Buserelin; Carcinogens; Cyclic AMP; Enzyme Activation; Female; Gonadotropin-Releasing Hormone; GTP-Binding Protein alpha Subunits; GTP-Binding Protein alpha Subunits, Gi-Go; Heterotrimeric GTP-Binding Proteins; Luteoma; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Ovarian Neoplasms; Pertussis Toxin; Phospholipase D; Phospholipases A; Phosphorylation; Progesterone; Protein Kinase C; Rats; Rats, Sprague-Dawley; Signal Transduction; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 2003 |
GnRH receptors and GnRH endocrine effects on luteoma cells.
Topics: Animals; Antineoplastic Agents, Hormonal; Buserelin; Estradiol; Estrus; Female; Gonadotropin-Releasing Hormone; Iodine Radioisotopes; Kinetics; Luteoma; Organ Culture Techniques; Ovarian Neoplasms; Progesterone; Rats; Rats, Sprague-Dawley; Receptors, LHRH; Superovulation; Tumor Cells, Cultured | 1997 |
Alterations in intracellular messengers mobilized by gonadotropin-releasing hormone in an experimental ovarian tumor.
Topics: Animals; Buserelin; Calcium; Cell Membrane; Female; Gonadotropin-Releasing Hormone; Inositol Phosphates; Kinetics; Luteoma; Ovarian Neoplasms; Ovariectomy; Ovary; Rats; Rats, Sprague-Dawley; Receptors, LHRH; Second Messenger Systems; Thapsigargin | 1999 |